Home Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
Article
Licensed
Unlicensed Requires Authentication

Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome

  • Shuntaro Morikawa EMAIL logo , Kimihiko Moriya , Katsura Ishizu and Toshihiro Tajima
Published/Copyright: July 15, 2014

Abstract

Persistent Müllerian duct syndrome (PMDS) is an autosomal recessive disorder of sex development (DSD) characterized by the presence of Müllerian duct derivatives in 46, XY phenotypic males. To date, more than 50 different mutations of the anti-Müllerian hormone gene (AMH) have been reported. Here, we report two novel mutations of AMH in a Japanese patient with PMDS. A 1-year-old male presented with bilateral cryptorchidism and normal male external genitalia. A laparoscopic surgery revealed a uterus and fallopian tubes. Serum AMH was very low. The patient’s elder brother was also diagnosed as having PMDS at another hospital. Genetic analysis of AMH showed two novel mutations of p.N486T and p.V527L. Given that these two amino acids are well conserved among different species of AMH, the substitution of two amino acids might affect the normal function of AMH. In conclusion, PMDS should be included in differential diagnoses of cryptorchidism.


Corresponding author: Shuntaro Morikawa, MD, Department of Pediatrics, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-0835, Japan, Phone: +81-11-706-5954, Fax: +81-11-706-7898, E-mail:

References

1. Rey R. Anti-Müllerian hormone in disorders of sex determination and differentiation. Arq Bras Endocrinol Metab 2005;49:26–36.10.1590/S0004-27302005000100005Search in Google Scholar

2. Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update 2005;11:351–6.10.1093/humupd/dmi014Search in Google Scholar PubMed

3. di Clemente N, Belville C. Anti-Mullerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 2006;20:599–610.10.1016/j.beem.2006.09.004Search in Google Scholar PubMed

4. Renaud EJ, MacLaughlin DT, Oliva E, Rueda BR, Donahoe PK. Endometrial cancer is a receptor-mediated target for Mullerian inhibiting substance. Proc Natl Acad Sci USA 2005;102:111–6.10.1073/pnas.0407772101Search in Google Scholar PubMed PubMed Central

5. Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, et al. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol 2003;211:43–9.10.1016/j.mce.2003.09.010Search in Google Scholar PubMed

6. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Mullerian duct. Development 1994;120:189–97.10.1242/dev.120.1.189Search in Google Scholar PubMed

7. Josso N, Rey R, Picard JY. Testicular anti-Müllerian hormone: clinical applications in DSD. Semin Reprod Med 2012;30:189–97.Search in Google Scholar

8. Knebelmann B, Boussin L, Guerrier D, Legeai L, Kahn A, et al. Anti-Mullerian hormone Bruxelles: a nonsense mutation associated with the persistent Mullerian duct syndrome. Proc Natl Acad Sci 1991;88:3767–71.10.1073/pnas.88.9.3767Search in Google Scholar PubMed PubMed Central

9. Johansen ML, Hagen CP, Johannsen TH, Main KM, Picard JY, et al. Anti-Mullerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development. Int J Endocrinol 2013;2013:1–10.10.1155/2013/198698Search in Google Scholar PubMed PubMed Central

10. Grinspon RP, Bedecarras P, Ballerini MG, Iniguez G, Rocha A, et al. Early onset of primary hypogonadism revealed by serum anti-Mullerian hormone determination during infancy and childhood in trisomy 21. Int J Androl 2011;34:e487–98.10.1111/j.1365-2605.2011.01210.xSearch in Google Scholar PubMed

11. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–9.10.1038/nmeth0410-248Search in Google Scholar PubMed PubMed Central

12. Wongprasert H, Somanunt S, De Filippo R, Picard JY, Pitukcheewanont P. A novel mutation of anti-Mullerian hormone gene in Persistent Mullerian Duct Syndrome presented with bilateral cryptorchidism: a case report. J Pediatr Urol 2013;9:e147–9.10.1016/j.jpurol.2013.03.004Search in Google Scholar PubMed

13. Odi TO, Abdur-Rahman LO, Nasir AA. Persistent Mullerian duct syndrome: a case report and review of the literature. Afr J Paediatr Surg 2010;7:191–3.10.4103/0189-6725.70425Search in Google Scholar PubMed

14. Brandli DW, Akbal C, Eugsster E, Hadad N, Havlik RJ, et al. Persistent Mullerian duct syndrome with bilateral abdominal testis: surgical approach and review of the literature. J Pediatr Urol 2005;1:423–7.10.1016/j.jpurol.2005.03.011Search in Google Scholar PubMed

15. van der Zwan YG, Brüggenwirth HT, Drop SL, Wolffenbuttel KP, Madern GC, et al. A novel AMH missense mutation in a patient with persistent Müllerian duct syndrome. Sex Dev 2012;6: 279–83.10.1159/000339704Search in Google Scholar PubMed

16. Mazen I, Abdel Hamid MS, El-Gammal M, Aref A, Amr K. AMH gene mutations in two Egyptian families with persistent mullerian duct syndrome. Sex Dev 2011;5:277–80.10.1159/000334854Search in Google Scholar PubMed

17. Menabo S, Balsamo A, Nicoletti A, Gennari M, Pirazzoli P, et al. Three novel AMH gene mutations in a patient with persistent müllerian duct syndrome and normal AMH serum dosage. Horm Res 2008;70:124–8.10.1159/000137664Search in Google Scholar PubMed

18. Lang-Muritano M, Biason-Lauber A, Gitzelmann C, Belville C, Picard Y, et al. A novel mutation in the anti-Müllerian hormone gene as cause of persistent müllerian duct syndrome. Eur J Pediatr 2001;160:652–4.10.1007/s004310100840Search in Google Scholar PubMed

Received: 2014-3-5
Accepted: 2014-6-12
Published Online: 2014-7-15
Published in Print: 2014-11-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Cushing syndrome
  3. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome
  4. Cushing syndrome secondary to CRH-producing Wilms tumor in a 6 year old
  5. Cushing’s disease presenting as cholestatic hepatitis
  6. How early can one diagnose Cushing’s disease? An early diagnosis in a case of prepubertal Cushing’s disease
  7. Review article
  8. Subclinical hypothyroidism in childhood and adolescense
  9. Original articles
  10. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
  11. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia
  12. Measures of pituitary gland and stalk: from neonate to adolescence
  13. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?
  14. Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  15. Association of serum 25-hydroxyvitamin D with race/ethnicity and constitutive skin color in urban schoolchildren
  16. A nonsense thyrotropin receptor gene mutation (R609X) is associated with congenital hypothyroidism and heart defects
  17. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents
  18. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome – a Chinese experience
  19. Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
  20. Long-term outcomes of pediatric Graves’ disease
  21. Accessibility of the reference center as a protective factor against ketoacidosis at the onset of diabetes in children
  22. Vitamin D, parathormone, and insulin resistance in children born large for gestational age
  23. Prevalence of vitamin D deficiency in apparently healthy children in north India
  24. Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation – UAE Eastern Region experience
  25. Clinical and molecular studies related to bone metabolism in patients with congenital adrenal hyperplasia
  26. Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation
  27. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents
  28. Early infant feeding practice and childhood obesity: the relation of breast-feeding and timing of solid food introduction with childhood obesity
  29. Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1
  30. The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty
  31. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
  32. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension
  33. Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
  34. Patient reports
  35. Hereditary vitamin D rickets: a case series in a family
  36. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
  37. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure
  38. Acquired hypothyroidism due to iodine deficiency in an American child
  39. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
  40. Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report
  41. Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
  42. Congenital hyperinsulinism in a newborn with a novel homozygous mutation (p.Q392H) in the ABCC8 gene
  43. Short communications
  44. Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
  45. Post-hemorrhagic hydrocephalus and diabetes insipidus in preterm infants
  46. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease
  47. Letter to the Editor
  48. And what about septin 9 (SEPT9) as a binding partner of survivin in heart regeneration?
Downloaded on 4.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0111/html
Scroll to top button